Back
  1. Home
  2. Profile of Chloé Parulski (ULiège)
Profil

Parulski Chloé

Faculté de Médecine > Doct. scienc. biom. pharma.

Faculté de Médecine > Master spéc. biol. clin. (sc. pharma.)

ORCID
0000-0003-0432-7791
Main Referenced Co-authors
Evrard, Brigitte  (13)
Lechanteur, Anna  (13)
Jennotte, Olivier  (8)
Servais, Anne-Catherine  (8)
Gresse, Eva  (7)
Main Referenced Keywords
3D Printing (5); Itraconazole (5); Fused Deposition Modeling (4); 3D printing (3); Additive manufacturing (3);
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (9)
Center for Interdisciplinary Research on Medicines (CIRM) (3)
Centre Interfacultaire de Recherche du Médicament - CIRM (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (19)

Publications (total 19)

The most downloaded
155 downloads
Demelenne, A., Gou, M.-J., Nys, G., Parulski, C., Crommen, J., Servais, A.-C., & Fillet, M. (2020). Evaluation of Hydrophilic Interaction Liquid Chromatography, Capillary Zone Electrophoresis and Drift Tube Ion-Mobility Quadrupole Time Of Flight mass spectrometry for the characterization of phosphodiester and phosphorothioate oligonucleotides. Journal of Chromatography. A. doi:10.1016/j.chroma.2019.460716 https://hdl.handle.net/2268/242526

The most cited

75 citations (Scopus®)

Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020 https://hdl.handle.net/2268/261087

Parulski, C. (2023). Development of new solid oral formulations produced by hot-melt extrusion coupled with fused deposition modeling 3D printing [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/306815

Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (13 June 2023). Development of 3D printed mini-waffle shapes containing hydrocortisone for children's personalized medicine. International Journal of Pharmaceutics, 642 (123131). doi:10.1016/j.ijpharm.2023.123131
Peer Reviewed verified by ORBi

Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (27 April 2023). The future of 3D printing for personalized medicine: Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules? [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Parulski, C., Goebel, J., Bya, L.-A., Lechanteur, A., & Evrard, B. (20 March 2023). Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules for children’s personalized medicine? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France.

Parulski, C., Goebel, J., Bya, L.-A., Servais, A.-C., Lechanteur, A., & Evrard, B. (2023). Could 3D printed waffle shapes replace hydrocortisone capsules prepared in community pharmacies for children’s personalized medicine? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Ayyoubi, S., Van Kampen, E., Kocabas, L. I., Parulski, C., Lechanteur, A., Evrard, B., De Jager, K., Muller, E., Wilms, E. W., Meulenhoff, P. W. C., & Ruijgrok, E. J. (December 2022). 3D printed, personalized sustained release cortisol for patients with adrenal insufficiency. International Journal of Pharmaceutics, 630, 122466. doi:10.1016/j.ijpharm.2022.122466
Peer Reviewed verified by ORBi

Parulski, C., Gresse, E., Jennotte, O., Felten, A., Ziemons, E., Lechanteur, A., & Evrard, B. (31 August 2022). Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques? International Journal of Pharmaceutics, 626, 122157. doi:10.1016/j.ijpharm.2022.122157
Peer Reviewed verified by ORBi

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (30 March 2022). How do polymer composition and infill density of 3D printed oral forms influence the dissolution rate of a BCSII molecule ? [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Rotterdam, Netherlands.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (10 March 2022). How do infill density and polymer composition of 3D printed solid oral forms impact the dissolution profile of a BSCII drug ? [Paper presentation]. CRS Local Chapters meeting Aachen, Aachen, Germany.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Developement of stable amorphous solid dispersions by hot-melt extrusion coupled with 3D printing to enhance the dissolution rate of a BCSII active molecule: Impact of infill density and polymer composition [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020
Peer Reviewed verified by ORBi

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (26 May 2021). How do polymer composition and infill density of 3D printed tablets influence the dissolution rate of itraconazole ? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). How do infill density and polymer composition of tablets produced by hotmelt extrusion coupled with Fused Deposition Modeling 3D printing influence the dissolution profile of a BCS II molecule ? [Paper presentation]. CRS Local Chapter Meeting.

Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (04 March 2021). Investigation of the impact of polymer composition and infill density of solid oral forms produced by hot-melt extrusion coupled with 3D printing on the dissolution rate of itraconazole [Paper presentation]. CRS Local Chapter Meeting, Aachen, Germany.

Demelenne, A., Gou, M.-J., Nys, G., Parulski, C., Crommen, J., Servais, A.-C., & Fillet, M. (2020). Evaluation of Hydrophilic Interaction Liquid Chromatography, Capillary Zone Electrophoresis and Drift Tube Ion-Mobility Quadrupole Time Of Flight mass spectrometry for the characterization of phosphodiester and phosphorothioate oligonucleotides. Journal of Chromatography. A. doi:10.1016/j.chroma.2019.460716
Peer Reviewed verified by ORBi

Demelenne, A., Gou, M.-J., Nys, G., Parulski, C., Servais, A.-C., & Fillet, M. (11 December 2019). Ion mobility high resolution mass spectrometry coupled to HILIC and CZE for the characterization of phosphodiester and phosphorothioate oligonucleotides [Paper presentation]. 2nd Cirm Day, Liège, Belgium.

Demelenne, A., Gou, M.-J., Nys, G., Parulski, C., Servais, A.-C., & Fillet, M. (17 September 2019). Quality control of therapeutic phosphorothioate oligonucleotides by hydrophilic interaction liquid chromatography coupled with ION-MOBILITY QTOF [Paper presentation]. 30 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL & BIOMEDICAL ANALYSIS, Tel Aviv, Israel.

Demelenne, A., Gou, M.-J., Parulski, C., Servais, A.-C., & Fillet, M. (20 May 2019). Optimisation of the separation of therapeutic phosphorothioate oligonucleotides by hydrophilic interaction liquid chromatography and capillary zone electrophoresis [Paper presentation]. 20th Forum of Pharmaceutical Sciences.

Gou, M.-J., Demelenne, A., Parulski, C., Servais, A.-C., & Fillet, M. (19 December 2018). Quality control of therapeutic oligonucleotides using HILIC-UV and CZE-UV [Poster presentation]. CIRM Day, Liège, Belgium.

Contact ORBi